2021 IPO

Darktrace Stock

Enterprise immune system technology

Sign up today and learn more about Darktrace Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Insight Venture Partners


Cambridge, GB

Total Funding


About Darktrace Stock

Darktrace is one of the world’s fastest-growing cyber defense companies and a leader in Enterprise Immune System technology, a new category of cyber solutions based on pioneering Bayesian mathematics developed at the University of Cambridge. Darktrace addresses the challenge of insider threat and advanced cyber-attacks through its unique ability to detect previously unidentified threats in real time, as manifested in the emerging behaviors of the network, devices and individuals. Some of the world’s largest organizations rely on Darktrace’s adaptive, self-learning platform to spot anomalous activity within the enterprise, in sectors including energy and utilities, financial services, telecommunications, retail and transportation. Darktrace was founded by world-class machine learning specialists and operational government intelligence experts.


Funding History

January 2019$261M


Co-Chief Executive Officer

Nicole Eagan

Co-Chief Executive Officer

Poppy Gustafsson

Chief Technology Officer

Jack Stockdale

Chief Marketing Officer

Emily Orton

Chief Revenue Officer

Nick Trim


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: